By
Drug Target Review2024-05-28T12:00:02
Researchers found that relaxing glial spacing by targeting Plexin-B1 has great therapeutic potential for Alzheimer’s disease.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-18T07:00:00Z
Contributor Dr Bryan McClellan and Dr William Matsui, By Drug Target Review
2026-11-13T07:00:00Z
Contributor Dr Panos Roussos, By Drug Target Review
2023-03-30T09:15:30
Sponsored by Halo Labs
2026-10-21T15:00:00
Sponsored by Oxford Nanopore Technologies
2026-10-28T16:21:00
Contributor Dr Sonal Gupta and Dr David Lonard, By Drug Target Review
2023-03-08T16:29:20
Sponsored by Bio-Techne
2025-03-19T15:00:00
Sponsored by Eurofins DiscoverX
2026-08-26T07:00:00
Contributor Professor Paul O’Reilly, By Drug Target Review
Site powered by Webvision Cloud